0001209191-23-035613.txt : 20230608
0001209191-23-035613.hdr.sgml : 20230608
20230608211206
ACCESSION NUMBER: 0001209191-23-035613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MIDDLETON FRED A
CENTRAL INDEX KEY: 0001267959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 231003643
MAIL ADDRESS:
STREET 1: 400 SOUTH EL CAMINO REAL STE 1200
CITY: SAN MATEO
STATE: CA
ZIP: 94402-1708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CalciMedica, Inc.
CENTRAL INDEX KEY: 0001534133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452120079
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-952-5500
MAIL ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: CalciMedica, Inc. /DE/
DATE OF NAME CHANGE: 20230322
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG VISION, INC.
DATE OF NAME CHANGE: 20170717
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG, Inc.
DATE OF NAME CHANGE: 20150303
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-06
0
0001534133
CalciMedica, Inc.
CALC
0001267959
MIDDLETON FRED A
C/O CALCIMEDICA, INC.
505 COAST S. BLVD. #202
LA JOLLA
CA
92037
1
0
1
0
0
Common Stock
2023-06-06
4
P
0
500
4.8808
A
10500
D
Common Stock
2023-06-07
4
P
0
500
5.20
A
11000
D
Common Stock
703388
I
By Sanderling Venture Partners VI, L.P.
Common Stock
582757
I
By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock
17682
I
By Sanderling Ventures Management VI
Common Stock
7456
I
By Sanderling VI Beteligungs GmbH & Co KG
Common Stock
8884
I
By Sanderling VI Limited Partnership
Common Stock
240676
I
By Sanderling Ventures VII, L.P.
Common Stock
14425
I
By Sanderling Ventures VII Annex Fund, L.P.
Common Stock
63228
I
By Sanderling Ventures VII (Canada), L.P.
Common Stock
1548
I
By Sanderling Ventures Management VII
Common Stock
8176
I
By Golden Triangle Ventures, LLC
The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI, LP, Sanderling Venture Partners VI Co-Investment Fund, LP, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (together, the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VI Securities except to the extent of his pecuniary interest therein.
The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP, Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), LP and Sanderling Ventures VII Annex Fund, L.P. (together, the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VII Securities except to the extent of his pecuniary interest therein.
The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
By John Dunn, Attorney-in-Fact
2023-06-08